Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Mar 13.
Published in final edited form as: Adv Exp Med Biol. 2012;723:611–618. doi: 10.1007/978-1-4614-0631-0_78

Modeling the Structural Consequences of BEST1 Missense Mutations

Karina E Guziewicz 1, Gustavo D Aguirre 1, Barbara Zangerl 1,
PMCID: PMC3951900  NIHMSID: NIHMS557268  PMID: 22183385

78.1 Introduction

Bestrophinopathies are a group of inherited retinal disorders primarily caused by point mutations scattered throughout the entire BEST1 gene. In humans, most of these sequence alterations lead to Best vitelliform macular dystrophy (BVMD), and in dogs cause cmr, a retinal phenotype modeling BVMD (Guziewicz et al. 2007, 2011; Zangerl et al. 2010).

The BEST1 gene product, bestrophin-1 (Best1), is embedded in the basolateral plasma membrane of the RPE, where it functions as a Ca 2+ dependent anion channel (Marmorstein et al. 2000; Hartzell et al. 2008). Two different topological models of human bestrophin-1 (hBest1) have been proposed. Based on the hydropathy profile analysis, Tsunenari et al. predicted six hydrophobic domains with five transmembrane-spanning segments for the native hBest1 (Tsunenari et al. 2003). Milenkovic et al. proposed a plausible alternative model with four membrane-spanning regions that places residues 95–229 within the cytoplasmic matrix, forming an extensive intracellular loop (Milenkovic et al. 2007). Both models locate the N and C termini on the cytosolic side, and both predict transmembrane domains within the highly evolutionarily conserved N-terminal part of the protein.

Although remarkable progress has been made toward understanding the bestrophin-1 physiology (Sun et al. 2002; Yu et al. 2007; Milenkovic et al. 2007; Qu et al. 2009), our understanding of its complex function and pathological mechanism is still at an early stage. Hitherto, the molecular consequences of altered residues defining three mutational hotspots of the bestrophin-1 molecule (6–30aa, 80–105aa, and 293–312aa) have been the most extensively studied (for review see Hartzell et al. 2008; Boon et al. 2009). These studies established a primary link between BEST1 mutations and the anion channel malfunction, and provided multiple clues how a particular amino acid substitution may interfere with the protein functionality. In most cases, diminished or absent Cl current, altered anion permeability or defective membrane integration in association with bestrophinopathies have been reported (Hartzell et al. 2008; Boon et al. 2009; Xiao et al. 2010). Despite the indisputable advancements made in elucidation of bestrophin-1 pathogenic effects, expression and molecular kinetics of mutant transcripts, potential structural consequences, and its impact on the intracellular processing, were either not examined at all or just outlined in few cases (Hartzell et al. 2008; Boon et al. 2009).

We previously described three spontaneous canine bestrophin-1 (cBest1) mutations responsible for cmr, an autosomal recessive retinal disorder recognized in numerous dog breeds (Guziewicz et al. 2007; Zangerl et al. 2010). The distinct sequence alterations in cBEST1 include a nonsense transition (C73T/R25X) located in the first coding exon (cmr1), a missense substitution (G482A/G161D) affecting a conserved glycine residue (cmr2), and a frameshift mutation (C1388del/P463FS) resulting in a truncated protein shortened by 92 C-terminal aa (cmr3) (Guziewicz et al. 2007; Zangerl et al. 2010). Detailed studies on molecular consequences of cmr1 mutation verified the BEST1 null phenotype, where C73T/R25X premature stop encodes for a truncated protein not detectable in the homozygous mutant animals or in an in vitro model system (Guziewicz et al. 2011).

In the cmr2 model, the small (75 Da), neutral, and non-hydrophilic glycine residue at position 161 is replaced by a much larger (133 Da) highly hydrophilic and negatively charged aspartic acid. We speculated that this drastic amino acid change may cause defective intracellular trafficking due to the incorrect folding of the mutant protein that cannot pass the endoplasmic reticulum (ER) quality control system. Indeed, the in-depth characterization of pathogenic effects of G482A/G161D revealed mislocalization of the cmr2-bestrophin to the perinuclear space of the cells. Moreover, confocal immuno-fluorescence microscopy analysis indicated co-localization of cmr2 mutant protein with an ER marker, calnexin (Guziewicz et al. 2011). To further support our hypothesis on cmr2 protein misfolding and retention in the ER, we used computational approaches to predict the potential structural consequences of the G161D alteration.

78.2 Materials and Methods

78.2.1 Topology Prediction

Topological model of canine bestrophin-1 (NP_001091014) was predicted in silico using Classification and Secondary Structure Prediction of Membrane Proteins SOSUI Server v1.11 (http://bp.nuap.nagoya-u.ac.jp/sosui/; Hirokawa et al. 1998). The model was verified by TopPred II algorithm (Transmembrane Topology Prediction of Membrane Proteins: http://mobyle.pasteur.fr/cgi-bin/portal.py; Claros and von Heijne 1994). Transmembrane segment hydrophobicity scores were calculated according to the GES scale with a cutoff of (−c) 1.8 and (−p) 0.7 (Engelman et al. 1986).

78.2.2 Prediction of Protein Structure

Protein Homology/analogY Recognition Engine (PHYRE Server version 0.2) (http://www.sbg.bio.ic.ac.uk/phyre/; Bennett-Lovsey et al. 2008) was used to perform the secondary fold recognition analysis and tertiary structure prediction for cBest1 (1–296aa) and hBest1 (25–301aa) protein segments. For the putative cBest1 wild-type (WT) structure the estimated precision value (EPV) reached 85% with an e-value of 0.46; for the cmr2 mutant protein EPV of 75% and e-value of 0.7 was considered. The putative model structures for hBest1 WT (EPV of 80%, e-value of 0.5) and hBest1 I201T mutant (EPV of 85%, e-value of 0.43) were compared to the canine specific predictions. All structures were evaluated on 3D molecule viewer module of the Vector NTI™ 10 software package (Invitrogen).

78.3 Results

78.3.1 Canine Bestrophin-1 Topology

In silico analysis predicted four transmembrane-spanning regions for the native cBest1, orienting the N and C termini to the cytoplasm (Fig. 78.1). According to the SOSUI algorithm, the four most probable transmembrane segments are located at amino acids 32–54, 73–94, 231–253, and 265–287. This model further predicts large, relatively hydrophobic intracellular loop (95–230aa), harboring the G161 residue mutated in cmr2 (Fig. 78.1). To test whether the location of the transmembrane domains is affected by the cmr2 mutation, the G161D change was introduced into the protein sequence, and analyzed with the SOSUI algorithm. No effect on the cBest1 topological model was noted with the G161D substitution. The putative cBest1 topology model was verified by TopPred II algorithm (data not shown).

Fig. 78.1.

Fig. 78.1

A representative model of canine bestrophin-1 topology. Two independent computational algorithms (SOSUI, TopPred II) were used to estimate the number of transmembrane domains of the cBest1. Both, the hydropathy index of Kyte and Doolittle and the Goldman, Engelman, and Steitz (GES) hydrophobicity scale, predict four cBest1 transmembrane segments

78.3.2 Comparative Protein Modeling

The highly evolutionarily conserved N-terminal part (1–296aa fragment) was used for secondary and tertiary structure prediction of the native cBest1 or the G161D mutant variant (Fig. 78.2). Figure 78.2c–d1 illustrates the detailed structural environment of the wild-type residues in the native cBest1 in comparison to the cmr2 mutant model. Replacement of Gly by Asp at position 161 dramatically affects protein structure leading to disrupted intramolecular interactions of neighboring residues (Fig. 78.2b, d–d1). To assess the relevance of the canine specific findings to human bestrophinopathies, a putative 3D structure for hBest1 (25–301aa fragment) WT or comparable T602C/I201T mutant variant associated with Best disease (Lotery et al. 2000) was predicted by the same algorithm (Fig. 78.3). Significant changes in the I201T mutant protein inducing conformational rearrangements and altered inter-residue interactions are demonstrated in Fig. 78.3d–d1. Note that only three-dimensional models of EPV ≥ 75% were considered.

Fig. 78.2.

Fig. 78.2

3D representation of the native and cmr2 mutant 295aa long N-terminal cBest1 fragment. (a, b) Overview of the tertiary structure predictions; structural changes caused by G161D substitution are indicated by arrows. (c, d) Detailed structural environment of the wild-type residues in the native cBest1 (c) in comparison to the cmr2 mutant (d). Amino acids G161 (WT) and D161 (cmr2) are highlighted in yellow. (c1, d1) Higher resolution views of the regions denoted by the white square in (c) and (d); Note the significant changes in the amino acid constellations induced by G161D replacement. Color code bar: negatively charged aa are labeled in red, whereas positively charged are marked in blue

Fig. 78.3.

Fig. 78.3

Computational prediction of 3D models for the native hBest1 and I201T mutant variant (amino acids 25–301). Arrows indicate position of I201 WT residue (a) and T201 mutant (b). Panels (c, d) illustrate details of the putative tertiary structure calculated for the native hBest1 (c) vs. I201T mutant (d); (c1 ) and (d1 ) show magnifications of the portion denoted by the white square in the images (c) and (d). Wild-type residue I201 and mutant T201 are highlighted in yellow. Note the striking rearrangement of molecular interactions surrounding the T201 residue (d1 ). Color code bar: negatively charged aa are labeled in red, whereas positively charged are marked in blue

78.4 Discussion

Membrane proteins play a crucial role in biological systems as ion channels, pores, and receptors. Understanding their structure and dynamics is essential to expand our knowledge on fundamental aspects of cellular homeostasis. However, only a small fraction of these important proteins has been isolated so far, and the function of most still remains ambiguous. Reasons for this lag include difficulties in expressing such proteins in significant quantities, in isolating and purifying them considering their amphipathic character, and in crystallizing them (http://www.che.udel.edu/cobre/). The recent rapid advances in computer sciences have accelerated their applications to understand complex biological systems, which helped to tackle some of the experimental difficulties. As a consequence, theoretical simulations and computational design methods are now an integral part of biomedical research, becoming an exceptionally useful and powerful means for studying membrane proteins architecture and properties (Casadio et al. 2003). We used two independent computational topology algorithms to assess the putative topology model for cBest1 (Fig. 78.1). Our in silico prediction strongly supports the experimental hBest1 topology model of Milenkovic et al. (2007), which further suggests similar topology for all vertebrate bestrophins. Both models consist of four transmembrane domains in the N-terminus of the protein, separated by a larger intracellular loop, and orienting the C-terminus toward the cytosol (Fig. 78.1; Milenkovic et al. 2007).

The majority of the disease-causing missense mutations identified in humans affect folding or trafficking, rather than specifically affecting protein function (Sanders and Myers 2004). To date, all examined missense changes in the hBest1 were associated with functional consequences, implicating an impaired channel activity. This study demonstrates the potential structural consequences of G161D (cmr2) and comparable hBest1 point mutation, I201T, predicted by comparative modeling of the N-terminal part of bestrophin-1. Both analyzed mutations are substitutions replacing a highly evolutionary conserved amino acid with a much bulkier residue (cmr2) of different biochemical properties (cmr2, I201T). Such dramatic changes often affect structure of the encoded protein in the immediate vicinity of the residue, creating electrostatic disturbances and altering the intramolecular inter-actions (Figs. 78.2c1, d1 and 78.3c1, d1).

The predicted structural rearrangements caused by G161D are in good agreement with previous experiments. Wild type cBest1 is processed in the ER and targeted to the plasma membrane, reflecting normal biogenesis and trafficking of bestrophin-1, but the cmr2 mutant is retained in the ER (Guziewicz et al. 2011). These data indicate that at least a subset of BEST1 missense mutations may lead to the protein misassembly, and its build-up in the ER. Since the BVMD and cmr are disorders where subretinal deposits accumulate, this mechanism may have an influence on the nature of lesions observed as well as on the disease progression. To support this hypothesis detailed studies are required to further analyze the molecular changes in the early events of the structurally defective bestrophin-1 folding.

Bestrophins are recognized as one of the most mysterious proteins of all known ion channels. To date, Best1 function and kinetics are still not fully understood. Our studies provided new insights into molecular pathology of point mutations associated with cmr and Best disease, which is central to the pathogenesis of bestrophinopathies. Additional studies will be required to explore the biochemical and cellular consequences of BEST1 mutations, and clarify their impact on protein structure with relation to disease onset and progression.

Acknowledgments

This study was supported by The Foundation Fighting Blindness, NEI/NIH grant EY06855, EY17549, The Van Sloun Fund for Canine Genetic Research, Hope for Vision, and P30EY-001583.

References

  1. Bennett-Lovsey RM, Herbert AD, Sternberg MJ, et al. Exploring the extremes of sequence/structure space with ensemble fold recognition in the program Phyre. Proteins. 2008;70:611–625. doi: 10.1002/prot.21688. [DOI] [PubMed] [Google Scholar]
  2. Boon CJ, Klevering BJ, Leroy BP, et al. The spectrum of ocular phenotypes caused by mutations in the BEST1 gene. Prog Retin Eye Res. 2009;28:187–205. doi: 10.1016/j.preteyeres.2009.04.002. [DOI] [PubMed] [Google Scholar]
  3. Casadio R, Fariselli P, Martelli PL. In silico prediction of the structure of membrane proteins: is it feasible? Brief Bioinform. 2003;4:341–348. doi: 10.1093/bib/4.4.341. [DOI] [PubMed] [Google Scholar]
  4. Claros MG, von Heijne G. TopPred II: An Improved Software For Membrane Protein Structure Predictions. Comput Appl Biosci. 1994;10:685–686. doi: 10.1093/bioinformatics/10.6.685. [DOI] [PubMed] [Google Scholar]
  5. Engelman DM, Steitz TA, Goldman A. Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins. Annu Rev Biophys Biophys Chem. 1986;15:321–353. doi: 10.1146/annurev.bb.15.060186.001541. [DOI] [PubMed] [Google Scholar]
  6. Guziewicz KE, Zangerl B, Lindauer SJ, et al. Bestrophin gene mutations cause canine multifocal retinopathy: a novel animal model for best disease. Invest Ophthalmol Vis Sci. 2007;48:1959–1967. doi: 10.1167/iovs.06-1374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Guziewicz KE, Slavik J, Lindauer SJP, et al. Molecular consequences of BEST1 gene mutations in canine multifocal retinopathy predict functional implications for human bestrophinopathies. Invest Ophthalmol Vis Sci. 2011;52:4497–4505. doi: 10.1167/iovs.10-6385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hartzell HC, Qu Z, Yu K, et al. Molecular physiology of bestrophins: multifunctional membrane proteins linked to best disease and other retinopathies. Physiol Rev. 2008;88:639–672. doi: 10.1152/physrev.00022.2007. [DOI] [PubMed] [Google Scholar]
  9. Hirokawa T, Boon-Chieng S, Mitaku S. SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics. 1998;14:378–379. doi: 10.1093/bioinformatics/14.4.378. [DOI] [PubMed] [Google Scholar]
  10. Lotery AJ, Munier FL, Fishman GA, et al. Allelic variation in the VMD2 gene in best disease and age-related macular degeneration. Invest Ophthalmol Vis Sci. 2000;41:1291–1296. [PubMed] [Google Scholar]
  11. Marmorstein AD, Marmorstein LY, Rayborn M, et al. Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. Proc Natl Acad Sci USA. 2000;97:12758–12763. doi: 10.1073/pnas.220402097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Milenkovic VM, Rivera A, Horling F, et al. Insertion and topology of normal and mutant bestrophin-1 in the endoplasmic reticulum membrane. J Biol Chem. 2007;282:1313–1321. doi: 10.1074/jbc.M607383200. [DOI] [PubMed] [Google Scholar]
  13. Qu Z, Cheng W, Cui Y, et al. Human disease-causing mutations disrupt an N-C-terminal interaction and channel function of bestrophin 1. J Biol Chem. 2009;284:16473–16481. doi: 10.1074/jbc.M109.002246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sanders CR, Myers JK. Disease-related misassembly of membrane proteins. Annu Rev Biophys Biomol Struct. 2004;33:25–51. doi: 10.1146/annurev.biophys.33.110502.140348. [DOI] [PubMed] [Google Scholar]
  15. Sun H, Tsunenari T, Yau KW, et al. The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc Natl Acad Sci USA. 2002;99:4008–4013. doi: 10.1073/pnas.052692999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Tsunenari T, Sun H, Williams J, et al. Structure-function analysis of the bestrophin family of anion channels. J Biol Chem. 2003;278:41114–41125. doi: 10.1074/jbc.M306150200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Xiao Q, Hartzell HC, Yu K. Bestrophins and retinopathies. Pflugers Arch. 2010;460:559–569. doi: 10.1007/s00424-010-0821-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Yu K, Qu Z, Cui Y, et al. Chloride channel activity of bestrophin mutants associated with mild or late-onset macular degeneration. Invest Ophthalmol Vis Sci. 2007;48:4694–4705. doi: 10.1167/iovs.07-0301. [DOI] [PubMed] [Google Scholar]
  19. Zangerl B, Wickström K, Slavik J, et al. Assessment of canine BEST1 variations identifies new mutations and established an independent bestrophinopathy model (cmr3) in Lapponian Herders. Mol Vis. 2010;16:2791–2804. [PMC free article] [PubMed] [Google Scholar]

RESOURCES